Xellia Pharmaceuticals USA LLC, Buffalo Grove, Illinois, has been awarded a maximum $17,864,307 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for various pharmaceutical products. This was a competitive acquisition with 29 offers received. This is a nine-month base contract with eight one-year option periods and one 15-month option period. The ordering period end date is Aug. 31, 2024. Using customers are Army, Navy, Air Force, Marine Corps, and federal civilian agencies. Type of appropriation is fiscal 2023 through 2024 Warstopper Funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2D0-23-D-0004).